Keryx Biopharmaceuticals (KERX) Jumps On Trial Results
Tweet Send to a Friend
Shares of Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) are 25% higher today after the companyh announced results of the Open Label ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


